Sarcoma & GIST
Conference Coverage
SARCO24: Regorafenib falls short for treatment-refractory liposarcoma
Regorafenib fell short of improving progression-free survival in patients with treatment-refractory liposarcomas, Richard Reidel, MD, of Duke...
Conference Coverage
EPAZ: Pazopanib matches doxorubicin without the neutropenia in elderly patients
Pazopanib can be considered as a first line alternative treatment to doxorubicin in patients over age 60 with advanced, inoperable soft tissue...
Latest News
ENLIVEN: Pexidartinib improves symptoms, function in patients with advanced tenosynovial giant cell tumors
Pexidartinib significantly improved overall response rates and functioning in patients with advanced tenosynovial giant cell tumors (TGCT), based...
Conference Coverage
Youth with rhabdomyosarcoma see better survival with maintenance chemo
CHICAGO – These findings mark the first major advance for this rare cancer in 30 years and have led to a new standard of care in Europe.
Video
Maintenance chemo boosts survival for youth with high-risk rhabdomyosarcoma
CHICAGO - Lead study author Dr. Gianni Bisogno discusses the practice changing results and describes plans for a new trial to explore alternate...
Conference Coverage
cfDNA reveals targetable mutations in pediatric neuroblastoma, sarcoma
PITTSBURGH – ‘Liquid biopsy’ of patients with genetically profiled tumors showed potentially actionable somatic mutations and copy number...
Conference Coverage
Multiple solid tumors targeted by concept CAR T
PITTSBURGH – Could this CAR T therapy become a viable option against pediatric solid tumors?
Journal Club
Sarcoma dominance in uterine carcinosarcomas linked to decreased survival
From the Journals
Targetable genetic alterations found in 41% of soft tissue sarcomas
Next-generation sequencing results might prove useful for guiding targeted therapy that could improve the treatment outcomes of patients with...